A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle
source: pixabay.com

A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle

  It has been evident to scientists for years that Alzheimer’s disease, which affects about five million people in the U.S., is caused by an accumulation of two proteins within…

Continue Reading A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle
New Diagnostic Technique Helps to Predict Transplant Success in Those with Focal Segmental Glomerulosclerosis
sasint / Pixabay

New Diagnostic Technique Helps to Predict Transplant Success in Those with Focal Segmental Glomerulosclerosis

Focal segmental glomerulosclerosis (FSGS) is a kidney disease that often results in end-stage renal failure. A kidney transplant is the best way to treat this failure. The issue with this…

Continue Reading New Diagnostic Technique Helps to Predict Transplant Success in Those with Focal Segmental Glomerulosclerosis
New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future
source: pixabay.com

New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future

According to a story from Newswise, a team of scientists and researchers associated with Université de Montréal and CHU Sainte-Justine have recently completed a study that maps a cellular model…

Continue Reading New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future
Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease
source: pixabay.com

Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease

  Falls are a symptom that affect about 60% of those with Parkinson's disease. This symptom can be debilitating, as many injuries can be the result. The University of Bristol…

Continue Reading Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease
FDA’s Acceptance of AYVAKIT’s New Drug Application Offers Hope to Metastatic GIST Patients
source: pixabay.com

FDA’s Acceptance of AYVAKIT’s New Drug Application Offers Hope to Metastatic GIST Patients

  Surgery has been found to often be the best option towards a cure for a cancerous tumor (resectable) but there are many other tumors that are diagnosed as unresectable…

Continue Reading FDA’s Acceptance of AYVAKIT’s New Drug Application Offers Hope to Metastatic GIST Patients
New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome
source: pixabay.com

New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome

According to a story from Gurufocus, the precision medicines company IDEAYA Biosciences, Inc. and the Boston Children's Hospital have recently entered into a Sponsored Research Agreement. The arrangement will entail…

Continue Reading New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome
The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy
source: pixabay.com

The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy

According to an announcement from the Muscular Dystrophy Association, the organization has recently awarded a total of $1,076,232 in MDA Venture Philanthropy (MVP) funding towards the drug company AavantiBio, which…

Continue Reading The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy
Family Sues Prison Officials After “Deliberate Indifference” in Addison’s-Related Death
source: pixabay.com

Family Sues Prison Officials After “Deliberate Indifference” in Addison’s-Related Death

By Rachel Whetstone from In The Cloud Copy Justin Stufflebean was 27 years old when he died after being taken to Missouri Western Reception, Diagnostic and Correctional Center (WRDCC). He…

Continue Reading Family Sues Prison Officials After “Deliberate Indifference” in Addison’s-Related Death